PHYSICIAN ASSISTANT-VARIOUS Senate SponsorsSen. Ann Gillespie-Laura M. Murphy, Javier L. Cervantes, Terri Bryant and Mattie Hunter House Sponsors(Rep. Lakesia Collins, Dave Severin and Dagmara Avelar) 6/9/2023SenatePublic Act . . . . . . . . . 103-0065 225 ILCS 95/4from Ch. 111, par. 4604225 ILCS 95/5.5225 ILCS 95/6from Ch. 111, par. 4606225 ILCS 95/7from Ch. 111, par. 4607225 ILCS 95/7.5225 ILCS 95/7.7225 ILCS 95/7.8 new225 ILCS 95/7.9 new225 ILCS 95/17from Ch. 111, par. 4617225 ILCS 95/21from Ch. 111, par. 4621720 ILCS 570/102from Ch. 56 1/2, par. 1102720 ILCS 570/303.05Amends the Physician Assistant Practice Act of 1987. Changes the definition of "physician assistant", "physician assistant practice", "board", and "collaborating physician". Provides that a physician assistant shall be deemed by law to possess the ability to prescribe, dispense, order, administer, and procure drugs and medical devices without delegation of such authority by a physician. Provides that such ability shall include the prescribing of Schedule II, III, IV, and V controlled substances. Provides that to prescribe Schedule II, III, IV, or V controlled substances under the Act, a physician assistant shall obtain a mid-level practitioner controlled substances license. Provides that when a written collaboration agreement is required under the Act, delegation of prescriptive authority by a physician is not required. Provides that a physician assistant who files with the Department of Financial and Professional Regulation a notarized attestation of completion of at least 250 hours of continuing education or training and at least 2,000 hours of clinical experience after first attaining national certification shall not require a written collaborative agreement. Provides the specified scope of practice of a physician assistant with optimal practice authority. Provides that a physician assistant shall be able to hold more than one professional position. Makes changes in provisions concerning the physician assistant title, collaboration requirements, and the written collaborative agreement. Makes other changes and corresponding changes to the Act and to the Illinois Controlled Substances Act.Senate Committee Amendment No. 2 Deletes reference to:225 ILCS 95/7.8 new225 ILCS 95/7.9 new225 ILCS 95/17225 ILCS 95/21720 ILCS 570/102720 ILCS 570/303.05Adds reference to:225 ILCS 95/7.6 newReplaces everything after the enacting clause. Amends the Physician Assistant Practice Act of 1987. Provides that any physician assistant required to enter into a written collaborative agreement with a collaborating physician is authorized to continue to practice for up to 90 days after the termination of a written collaborative agreement, provided the physician assistant seeks any necessary collaboration at a local hospital and refers patients who require services beyond the training and experience of the physician assistant to a physician or other health care provider. Provides that physicians and physician assistants who work in a federally qualified health center are exempt from specified collaborative ratio restriction requirements. Adds physician assistants providing services in federally qualified health centers to provisions that authorize certain physician assistants to provide services without a written collaborative agreement and to prescribe certain controlled substances. Defines "federally qualified health center". Makes conforming and other changes. 1/31/2023SenateFiled with Secretary by Sen. Ann Gillespie 1/31/2023SenateFirst Reading 1/31/2023SenateReferred to Assignments 2/6/2023SenateAdded as Chief Co-Sponsor Sen. Laura M. Murphy 2/7/2023SenateAssigned to Licensed Activities 2/22/2023SenateAdded as Co-Sponsor Sen. Javier L. Cervantes 2/23/2023SenatePostponed - Licensed Activities 2/23/2023SenateAdded as Co-Sponsor Sen. Terri Bryant 3/9/2023SenatePostponed - Licensed Activities 3/10/2023SenateRule 2-10 Committee Deadline Established As March 24, 2023 3/23/2023SenatePostponed - Licensed Activities 3/23/2023SenateRule 2-10 Committee Deadline Established As March 31, 2023 3/24/2023SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Ann Gillespie 3/24/2023SenateSenate Committee Amendment No. 1 Referred to Assignments 3/28/2023SenateSenate Committee Amendment No. 1 Assignments Refers to Licensed Activities 3/28/2023SenateSenate Committee Amendment No. 2 Filed with Secretary by Sen. Ann Gillespie 3/28/2023SenateSenate Committee Amendment No. 2 Referred to Assignments 3/29/2023SenateSenate Committee Amendment No. 2 Assignments Refers to Licensed Activities 3/29/2023SenateSenate Committee Amendment No. 2 Adopted; Licensed Activities 3/29/2023SenateSenate Committee Amendment No. 1 Postponed - Licensed Activities 3/30/2023SenateDo Pass as Amended Licensed Activities; 009-000-000 3/30/2023SenatePlaced on Calendar Order of 2nd Reading 3/30/2023SenateSecond Reading 3/30/2023SenatePlaced on Calendar Order of 3rd Reading March 31, 2023 3/31/2023SenateThird Reading - Passed; 052-000-000 3/31/2023SenateSenate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a) 3/31/2023SenateAdded as Co-Sponsor Sen. Mattie Hunter 3/31/2023HouseArrived in House 3/31/2023HouseChief House Sponsor Rep. Lakesia Collins 4/11/2023HouseFirst Reading 4/11/2023HouseReferred to Rules Committee 4/11/2023HouseAssigned to Health Care Licenses Committee 4/19/2023HouseDo Pass / Short Debate Health Care Licenses Committee; 012-000-000 4/19/2023HousePlaced on Calendar 2nd Reading - Short Debate 5/3/2023HouseSecond Reading - Short Debate 5/3/2023HousePlaced on Calendar Order of 3rd Reading - Short Debate 5/8/2023HouseThird Reading - Short Debate - Passed 103-000-000 5/8/2023HouseAdded Alternate Co-Sponsor Rep. Dave Severin 5/8/2023HouseAdded Alternate Co-Sponsor Rep. Dagmara Avelar 5/8/2023SenatePassed Both Houses 6/6/2023SenateSent to the Governor 6/9/2023SenateGovernor Approved 6/9/2023SenateEffective Date January 1, 2024 6/9/2023SenatePublic Act . . . . . . . . . 103-0065